4//SEC Filing
Tessari Eben 4
Accession 0001867899-25-000011
CIK 0001730430other
Filed
Nov 30, 7:00 PM ET
Accepted
Dec 1, 4:37 PM ET
Size
8.9 KB
Accession
0001867899-25-000011
Insider Transaction Report
Form 4
Tessari Eben
CHIEF OPERATING OFFICER
Transactions
- Exercise/Conversion
Class A Ordinary Share
2025-11-26$22.89/sh+200$4,578→ 22,914 total - Sale
Class A Ordinary Share
2025-11-26$42.89/sh−200$8,578→ 22,714 total - Exercise/Conversion
Share Option
2025-11-26−200→ 46,938 totalExercise: $22.89Exp: 2031-03-15→ Class A Ordinary Share (200 underlying)
Footnotes (2)
- [F1]This transaction was effected pursuant to a 10b5-1 plan executed by the reporting person on April 29, 2024.
- [F2]The option is fully vested and exercisable.
Documents
Issuer
Kiniksa Pharmaceuticals International, plc
CIK 0001730430
Entity typeother
Related Parties
1- filerCIK 0001867899
Filing Metadata
- Form type
- 4
- Filed
- Nov 30, 7:00 PM ET
- Accepted
- Dec 1, 4:37 PM ET
- Size
- 8.9 KB